We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A new study found that infections caused by the drug resistant bacteria – methicillin-resistant Staphylococcus aureus, known as MRSA – are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria.